Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2023 (1)
  • 2022 (1)
  • 2021 (6)
  • 2020 (2)

Subject

  • Prescription Drugs (5)
  • Diversion Division (2)
  • Drug Trafficking (2)
  • Outreach/Drug Prevention (2)
  • Pharmaceuticals/Pharmacists/Physicians (2)
  • Arrests/Convictions - Major (1)
  • Guilty Plea (1)
  • Major Law Enforcement Operation (1)
  • Overdose (1)
  • Press Conferences (1)
  • Public and Media Affairs - also see Congressional Affairs (1)

Drug Name

  • Fentanyl (81)
  • Methamphetamine (52)
  • Cocaine (47)
  • Heroin (26)
  • Marijuana (Cannabis) (11)
  • Oxycodone (10)
  • Synthetic Opioids (8)
  • Ecstasy/MDMA (2)
  • Marijuana Concentrates (2)
  • Steroids (2)
  • Amphetamines (1)
  • GHB (1)
  • Hydromorphone (1)
  • Ketamine (1)
  • Morphine (1)
  • Psilocybin (1)
  • Opioids (10)

Field Division

  • Washington, DC (55)
  • Miami (9)
  • Seattle (8)
  • Atlanta (7)
  • San Francisco (6)
  • New England (5)
  • Chicago (4)
  • Houston (4)
  • New York (3)
  • St. Louis (3)
  • New Jersey (2)
  • Detroit (1)
  • Rocky Mountain (1)
  • San Diego (1)
  • Dallas (5)
  • Sede (5)
Clear All Results
PRESS RELEASE

Denton Physician Sentenced for Over-Prescribing Opioids

Mayo 19, 2023
DALLAS, TX – A Denton physician has been sentenced to federal prison for drug trafficking violations announced Special Agent in Charge of the DEA Dallas Eduardo A. Chávez today. Stanley Charles Evans, 63, pleaded guilty on Sep. 12, 2022, to conspiracy to distribute and dispense controlled substances and health care...
Mayo 19, 2023
PRESS RELEASE

Arlington Doctor Sentenced to 12 Years in Pill Mill Case

Marzo 25, 2022
DALLAS, TX- An Arlington physician has been sentenced to 12 years in federal prison for fraud and drug crimes, announced DEA Special Agent in Charge Eduardo A. Chávez. In July 2021, a federal jury convicted physician Clinton Battle, 69, of one count of conspiracy to distribute controlled substances and one...
Marzo 25, 2022
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

Noviembre 30, 2021
Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
Noviembre 30, 2021
PRESS RELEASE

Administrator Anne Milgram Remarks on the Overdose Epidemic

Noviembre 17, 2021
Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...
Noviembre 17, 2021
PRESS RELEASE

Arlington Doctor and Nurse Practitioner Found Guilty of Operating a Pill Mill

Julio 07, 2021
DALLAS - An Arlington physician has been convicted of drug crimes, announced today by DEA Dallas Special Agent in Charge Eduardo A. Chávez Following five days of trial, a federal jury convicted physician Clinton Battle, 68, of one count of conspiracy to distribute controlled substances and one count of distribution...
Julio 07, 2021
PRESS RELEASE

DEA Finalizes Measures to Expand Medication-Assisted Treatment

Junio 28, 2021
WASHINGTON – The Drug Enforcement Administration today announced an important step to improve access to medications for opioid use disorder, especially in rural areas where those suffering with opioid use disorder may have limited treatment options. Under the final rule published today, DEA registrants who are authorized to dispense methadone...
Junio 28, 2021
PRESS RELEASE

Doctor Convicted of Second Degree Murder

Abril 30, 2021
OKLAHOMA CITY - On April 30, 2021, a state jury in Oklahoma City, Oklahoma convicted Dr. Regan Nichols of one count of second degree murder in relation to the death of one of her patients. Nichols was originally charged with five counts of second degree murder in relation to the...
Abril 30, 2021
PRESS RELEASE

DEA honors federal prosecutors for exemplary work in drug-related cases

Enero 29, 2021
SAN DIEGO – The Drug Enforcement Administration San Diego Field Division presented awards to several federal prosecutors for their exemplary service and dedication to DEA’s mission in San Diego and the surrounding counties. “It was an honor and a privilege to recognize these Assistant U.S. Attorneys along with U.S. Attorney...
Enero 29, 2021
PRESS RELEASE

DEA announces launch of Project Safeguard

Octubre 20, 2020
WASHINGTON – Drug Enforcement Administration Acting Administrator Timothy J. Shea today announced that the DEA will direct resources to help reduce violent crime in communities throughout the country. Under this initiative, called Project Safeguard, DEA will identify and prioritize ongoing drug trafficking investigations with a nexus to violent crime. “D...
Octubre 20, 2020
PRESS RELEASE

International law enforcement operation targeting opioid traffickers on the Darknet results in over 170 arrests worldwide and the seizure of weapons, drugs and over $6.5 million

Septiembre 22, 2020
WASHINGTON – Today, the Department of Justice, through the Joint Criminal Opioid and Darknet Enforcement team, joined Europol to announce the results of Operation DisrupTor, a coordinated international effort to disrupt opioid trafficking on the Darknet. The operation, which was conducted across the United States and Europe, demonstrates the continued...
Septiembre 22, 2020
Showing 1 - 10 of 10 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster